Bringing the power of tandem mass spectrometry to clinical research Clinical research laboratories throughout the world are discovering the analytical power of LC/MS/MS and its ability to accurately identify and quantify minute amounts of compounds in complex sample matrices such as blood, urine and oral fluid. Increasingly, innovative LC/MS/MS methods are being used in place of conventional analysis to study inborn errors of metabolism and metabolic profiles, and to identify therapeutic drugs, drugs of abuse, disease markers, and toxic compounds. As the leader in LC/MS/MS, Applied Biosystems/MDS SCIEX is working closely with clinical research laboratories throughout the world to develop these and other applications for this fast, sensitive and robust technology. Mass Spectrometers are general purpose laboratory instruments. They have not been cleared or approved by the United States Food and Drug Administration or any other agency, or under the European IVD Directive, for diagnostic or other clinical use.			Immunosuppressant's webinar AAA45/32™ kits Product bulletin Cliquid® Quant Software Cliquid® Drug Screen & Quant Software Applications overview Therapeutic Drug Efficacy Inborn Errors of Metabolism Biomarkers Toxicology Why Use LC/MS/MS LC/MS/MS Product Overview Triple Quadrupole Systems Hybrid Triple Quadrupole/Linear Ion Trap Systems Ion sources Analyst® Software MarkerView™ Software Cliquid® Quant Software Cliquid® Drug Screen & Quant Software View presentations from leading experts Dr. Soldin, Georgetown University, USA Dr. Rauh, University Children's Hospital, Germany Dr. Allen, Leeds Teaching Hospitals, UK Pr. Oellerich, George August University, Germany Pharma Applications Forensic and Toxicology Applications Services Information Contact me Notify a colleague